المؤلفون: Hussain M; University of Michigan, Division of Hematology/Oncology, 1500 E Medical Center Dr., 7314 CC, Ann Arbor, MI 48109-0946, USA. mahahuss@umich.edu, Tangen CM, Berry DL, Higano CS, Crawford ED, Liu G, Wilding G, Prescott S, Kanaga Sundaram S, Small EJ, Dawson NA, Donnelly BJ, Venner PM, Vaishampayan UN, Schellhammer PF, Quinn DI, Raghavan D, Ely B, Moinpour CM, Vogelzang NJ, Thompson IM Jr

المصدر: The New England journal of medicine [N Engl J Med] 2013 Apr 04; Vol. 368 (14), pp. 1314-25.

نوع المنشور: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE

مواضيع طبية MeSH: Quality of Life*, Androgen Antagonists/*administration & dosage , Anilides/*administration & dosage , Gonadotropin-Releasing Hormone/*analogs & derivatives , Goserelin/*administration & dosage , Nitriles/*administration & dosage , Prostatic Neoplasms/*drug therapy , Tosyl Compounds/*administration & dosage, Aged ; Anilides/adverse effects ; Antineoplastic Agents, Hormonal/administration & dosage ; Antineoplastic Agents, Hormonal/adverse effects ; Confidence Intervals ; Drug Administration Schedule ; Follow-Up Studies ; Gonadotropin-Releasing Hormone/therapeutic use ; Goserelin/adverse effects ; Humans ; Male ; Middle Aged ; Neoplasm Metastasis/drug therapy ; Nitriles/adverse effects ; Penile Erection/drug effects ; Prostate-Specific Antigen/blood ; Prostatic Neoplasms/mortality ; Prostatic Neoplasms/pathology ; Survival Analysis ; Tosyl Compounds/adverse effects